Table 3.
Cytotoxic effect of TB-EO on human cancer cell lines.
| IC50 (µg/mL) | ||||
|---|---|---|---|---|
| Compound | HeLa-R2 | LS-174-D3 | A-549-C5 | >MRC-5 |
| TB-EO | 7.22 ± 1.21 | 9.30 ± 0.84 | 8.62 ± 1.41 | 118.34 ± 0.56 |
| Cisplatin | 4.24 ± 0.81 | 5.21 ± 0.23 | 5.43 ± 0.34 | 10.08 ± 0.71 |
Values presented are means ± standard deviation (SD) of three independent experiments performed in triplicates. HeLa-R2: Human cervical carcinoma cells; LS-174-D3: Colon cancer cells; A-549-C5: Lung adenocarcinoma cells; MRC-5: Normal human fetal lung fibroblast cells; TB-EO: T. bovei essential oil; IC50: The concentration of drug that possesses 50% inhibition of cell survival.